What is the ticker symbol for NeuBase Therapeutics?

NeuBase Therapeutics trades under the ticker NBSE on NASDAQ.

What sector does NeuBase Therapeutics operate in?

NeuBase Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze NBSE in a portfolio?

PortView shows NBSE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

NeuBase Therapeutics (NBSE) Stock Analysis

NASDAQHealthcareBiotechnology

$0.38-1.56%

1-year price historyRange $0.38 – $3.74

52-week range$0.38

$0.36$4.44

What NeuBase Therapeutics does

Operating as a pre-clinical biopharmaceutical company, NeuBase Therapeutics, Inc. is dedicated to pioneering therapeutic solutions for rare genetic disorders and various cancers stemming from aberrant genes. At the core of its approach is the proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform. This technology is being utilized to target ailments such as Huntington's disease (HD) and myotonic dystrophy, in addition to a broader spectrum of genetic conditions and applications within oncology. The company's leading therapeutic candidates encompass NT0100, a PATrOL-powered anti-gene therapy for Huntington's disease; NT0200, another PATrOL-enabled anti-gene solution for myotonic dystrophy type 1; and NT0300, a PATrOL-based treatment specifically engineered to address the mutated KRAS gene. NeuBase Therapeutics, Inc. maintains its headquarters in Pittsburgh, Pennsylvania.

Key metrics

Market cap

$1.42M

P/E (TTM)

-0.02

EPS (TTM)

$-18.60

Beta

0.94

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$0.47

200-day avg

$0.72

52-week high

$4.44

52-week low

$0.36

CEO

Todd P. Branning

ETFs linked to NBSE

Broad-market and Healthcare sector ETFs an investor holding NeuBase Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how NBSE fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NBSE in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for NeuBase Therapeutics?: NeuBase Therapeutics trades under the ticker NBSE on NASDAQ.
Which exchange is NBSE listed on?: NBSE is listed on NASDAQ.
What sector does NeuBase Therapeutics operate in?: NeuBase Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze NBSE in a portfolio?: PortView shows NBSE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.